Register Now: IKRIS Breast Cancer Awareness Run 2022

Tag Archives: Cemiplimab

FDA approves Cemiplimab as first immunotherapy to treat patients with advanced BCC.

As a monoclonal antibody medication, the FDA has approved cemiplimab (Libtayo) in order to treat patients with advanced BCC (Basal […]

ikrisuser
February 15, 2021